Effects of pravastatin on ventricular remodeling by activation of myocardial KATP channels in infarcted rats: Role of70-kDa S6 kinase

Tsung-Ming Lee, Mei Shu Lin, Chang Her Tsai, Ne Chung Chang

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Reactive cardiomyocyte hypertrophy after myocardial infarction is an important risk factor for arrhythmias. Myocardial ATP-sensitive potassium (KATP) channels have been implicated in attenuating cardiac hypertrophyby inhibition of 70-kDa S6 kinase. We investigated the effect of pravastatin on ventricular hypertrophy during remodeling after myocardial infarction and whether the attenuated hypertrophic effect was via activation of myocardial KATP channels. Twenty-four hours after ligation of the anterior descending artery, male Wistar rats were randomized to either vehicle, nicorandil (an agonist of KATP channels), pravastatin, glibenclamide (an antagonist of KATP channels), or a combination of nicorandil and glibenclamide orpravastatin and glibenclamide for 4 weeks. Infarct size and mortality weresimilar among the infarcted groups. Cardiomyocyte sizes isolated by enzymatic dissociation after infarction significantly increased at the border zonein vehicle-treated infarcted rats compared with sham-operated rats. Rats inthe nicorandil- and pravastatin-treated groups significantly attenuated cardiomyocyte hypertrophy, as compared with the vehicle-treated group. Arrhythmicscores during programmed stimulation mirrored those of cardiomyocyte hypertrophy. Increased 70-kDa S6 kinase mRNA expression in cardiac remodeling was confirmed by reverse transcription-polymerase chain reaction, consistent with the results of immunohistochemistry and Western blot for the phosphorylation of 70-kDa S6 kinase. Nicorandil-induced effects were abolished by administering glibenclamide. Similarly, the beneficial effects of pravastatin were abolished by administering glibenclamide, implicating KATP channels as the relevant target. Activation of KATPchannels by pravastatin administration can attenuate ventricular remodeling through a S6 kinase-dependent pathway after infarction.

Original languageEnglish
Pages (from-to)171-182
Number of pages12
JournalBasic Research in Cardiology
Volume102
Issue number2
DOIs
Publication statusPublished - Mar 2007

Fingerprint

Ribosomal Protein S6 Kinases
Pravastatin
KATP Channels
Ventricular Remodeling
Glyburide
Nicorandil
Cardiac Myocytes
Hypertrophy
Infarction
Myocardial Infarction
Reverse Transcription
Ligation
Wistar Rats
Cardiac Arrhythmias
Arteries
Western Blotting
Immunohistochemistry
Phosphorylation
Polymerase Chain Reaction
Messenger RNA

Keywords

  • Arrhythmia
  • Ion channels
  • Remodeling
  • Statins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effects of pravastatin on ventricular remodeling by activation of myocardial KATP channels in infarcted rats : Role of70-kDa S6 kinase. / Lee, Tsung-Ming; Lin, Mei Shu; Tsai, Chang Her; Chang, Ne Chung.

In: Basic Research in Cardiology, Vol. 102, No. 2, 03.2007, p. 171-182.

Research output: Contribution to journalArticle

@article{4f41b3dd0eb246a3b63390a26b340334,
title = "Effects of pravastatin on ventricular remodeling by activation of myocardial KATP channels in infarcted rats: Role of70-kDa S6 kinase",
abstract = "Reactive cardiomyocyte hypertrophy after myocardial infarction is an important risk factor for arrhythmias. Myocardial ATP-sensitive potassium (KATP) channels have been implicated in attenuating cardiac hypertrophyby inhibition of 70-kDa S6 kinase. We investigated the effect of pravastatin on ventricular hypertrophy during remodeling after myocardial infarction and whether the attenuated hypertrophic effect was via activation of myocardial KATP channels. Twenty-four hours after ligation of the anterior descending artery, male Wistar rats were randomized to either vehicle, nicorandil (an agonist of KATP channels), pravastatin, glibenclamide (an antagonist of KATP channels), or a combination of nicorandil and glibenclamide orpravastatin and glibenclamide for 4 weeks. Infarct size and mortality weresimilar among the infarcted groups. Cardiomyocyte sizes isolated by enzymatic dissociation after infarction significantly increased at the border zonein vehicle-treated infarcted rats compared with sham-operated rats. Rats inthe nicorandil- and pravastatin-treated groups significantly attenuated cardiomyocyte hypertrophy, as compared with the vehicle-treated group. Arrhythmicscores during programmed stimulation mirrored those of cardiomyocyte hypertrophy. Increased 70-kDa S6 kinase mRNA expression in cardiac remodeling was confirmed by reverse transcription-polymerase chain reaction, consistent with the results of immunohistochemistry and Western blot for the phosphorylation of 70-kDa S6 kinase. Nicorandil-induced effects were abolished by administering glibenclamide. Similarly, the beneficial effects of pravastatin were abolished by administering glibenclamide, implicating KATP channels as the relevant target. Activation of KATPchannels by pravastatin administration can attenuate ventricular remodeling through a S6 kinase-dependent pathway after infarction.",
keywords = "Arrhythmia, Ion channels, Remodeling, Statins",
author = "Tsung-Ming Lee and Lin, {Mei Shu} and Tsai, {Chang Her} and Chang, {Ne Chung}",
year = "2007",
month = "3",
doi = "10.1007/s00395-006-0628-x",
language = "English",
volume = "102",
pages = "171--182",
journal = "Basic Research in Cardiology",
issn = "0300-8428",
publisher = "D. Steinkopff-Verlag",
number = "2",

}

TY - JOUR

T1 - Effects of pravastatin on ventricular remodeling by activation of myocardial KATP channels in infarcted rats

T2 - Role of70-kDa S6 kinase

AU - Lee, Tsung-Ming

AU - Lin, Mei Shu

AU - Tsai, Chang Her

AU - Chang, Ne Chung

PY - 2007/3

Y1 - 2007/3

N2 - Reactive cardiomyocyte hypertrophy after myocardial infarction is an important risk factor for arrhythmias. Myocardial ATP-sensitive potassium (KATP) channels have been implicated in attenuating cardiac hypertrophyby inhibition of 70-kDa S6 kinase. We investigated the effect of pravastatin on ventricular hypertrophy during remodeling after myocardial infarction and whether the attenuated hypertrophic effect was via activation of myocardial KATP channels. Twenty-four hours after ligation of the anterior descending artery, male Wistar rats were randomized to either vehicle, nicorandil (an agonist of KATP channels), pravastatin, glibenclamide (an antagonist of KATP channels), or a combination of nicorandil and glibenclamide orpravastatin and glibenclamide for 4 weeks. Infarct size and mortality weresimilar among the infarcted groups. Cardiomyocyte sizes isolated by enzymatic dissociation after infarction significantly increased at the border zonein vehicle-treated infarcted rats compared with sham-operated rats. Rats inthe nicorandil- and pravastatin-treated groups significantly attenuated cardiomyocyte hypertrophy, as compared with the vehicle-treated group. Arrhythmicscores during programmed stimulation mirrored those of cardiomyocyte hypertrophy. Increased 70-kDa S6 kinase mRNA expression in cardiac remodeling was confirmed by reverse transcription-polymerase chain reaction, consistent with the results of immunohistochemistry and Western blot for the phosphorylation of 70-kDa S6 kinase. Nicorandil-induced effects were abolished by administering glibenclamide. Similarly, the beneficial effects of pravastatin were abolished by administering glibenclamide, implicating KATP channels as the relevant target. Activation of KATPchannels by pravastatin administration can attenuate ventricular remodeling through a S6 kinase-dependent pathway after infarction.

AB - Reactive cardiomyocyte hypertrophy after myocardial infarction is an important risk factor for arrhythmias. Myocardial ATP-sensitive potassium (KATP) channels have been implicated in attenuating cardiac hypertrophyby inhibition of 70-kDa S6 kinase. We investigated the effect of pravastatin on ventricular hypertrophy during remodeling after myocardial infarction and whether the attenuated hypertrophic effect was via activation of myocardial KATP channels. Twenty-four hours after ligation of the anterior descending artery, male Wistar rats were randomized to either vehicle, nicorandil (an agonist of KATP channels), pravastatin, glibenclamide (an antagonist of KATP channels), or a combination of nicorandil and glibenclamide orpravastatin and glibenclamide for 4 weeks. Infarct size and mortality weresimilar among the infarcted groups. Cardiomyocyte sizes isolated by enzymatic dissociation after infarction significantly increased at the border zonein vehicle-treated infarcted rats compared with sham-operated rats. Rats inthe nicorandil- and pravastatin-treated groups significantly attenuated cardiomyocyte hypertrophy, as compared with the vehicle-treated group. Arrhythmicscores during programmed stimulation mirrored those of cardiomyocyte hypertrophy. Increased 70-kDa S6 kinase mRNA expression in cardiac remodeling was confirmed by reverse transcription-polymerase chain reaction, consistent with the results of immunohistochemistry and Western blot for the phosphorylation of 70-kDa S6 kinase. Nicorandil-induced effects were abolished by administering glibenclamide. Similarly, the beneficial effects of pravastatin were abolished by administering glibenclamide, implicating KATP channels as the relevant target. Activation of KATPchannels by pravastatin administration can attenuate ventricular remodeling through a S6 kinase-dependent pathway after infarction.

KW - Arrhythmia

KW - Ion channels

KW - Remodeling

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=33846707632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846707632&partnerID=8YFLogxK

U2 - 10.1007/s00395-006-0628-x

DO - 10.1007/s00395-006-0628-x

M3 - Article

C2 - 17031758

AN - SCOPUS:33846707632

VL - 102

SP - 171

EP - 182

JO - Basic Research in Cardiology

JF - Basic Research in Cardiology

SN - 0300-8428

IS - 2

ER -